MELIMEDI
ActiveSummary
MELIMEDI has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,657 and a net result of €28,157. Its solvency ranks better than 78% of 3,009 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
No sitting directors or connected companies in the Gazette act read.